|
CLN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
4.025900002258E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
3.682500E-02 |
| Stage1-vs-Stage3 |
8.890100E-02 |
| Stage1-vs-Stage4 |
1.769620E-04 |
| Stage2-vs-Stage3 |
2.575700E-03 |
| Stage2-vs-Stage4 |
1.241180E-04 |
| Stage3-vs-Stage4 |
1.499400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.11022302462516E-16 |
| Normal-vs-AfricanAmerican |
1.57529989053273E-10 |
| Normal-vs-Asian |
1.62447832963153E-12 |
| Caucasian-vs-AfricanAmerican |
9.701000E-01 |
| Caucasian-vs-Asian |
8.818200E-01 |
| AfricanAmerican-vs-Asian |
8.986400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.177600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62592161956354E-12 |
| Normal-vs-Age(81-100Yrs) |
4.23260000004255E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.227600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.078200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.404000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.457200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.247800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.549200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.06619999998381E-07 |
| Classical-VS-Follicular |
4.46320000002665E-06 |
| Classical-VS-Other |
5.793600E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
2.90723001228343E-12 |
| Tall-VS-Other |
3.744600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
6.364400E-02 |
| Follicular-VS-Normal |
1.29699999629196E-08 |
| Other-VS-Normal |
2.20409999995841E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
4.74380000003993E-06 |
|
|
